Taro Pharmaceutical was one of the rare exceptions of a stock that advanced while the S&P 500 descended into a bear market.

AFTER AMERICA, China is the world’s largest developer of new medicines. Its companies ran nearly a third of the planet’s clinical trials last year. That is up from just 5% a decade before (see chart 1 ...

In this week’s edition of InnovationRx, we look at the biotech deal frenzy, Recursion’s incoming CEO, the infant formula botulism outbreak, and more. To get it in your inbox, subscribe here. Merck ...

GameSpot may get a commission from retail offers. For the last two decades, Yoko Taro has found success with the Drakengard and Nier franchise(s), but he hasn't had a new game since the Voice of Cards ...

Yoko Taro, the creator of the Nier and Drakenguard games, has been awfully quiet lately. Though he's worked on some smaller projects (writing scenarios for Voice of Cards, and a few mobile games), the ...

A federal judge officially approved drugmaker Purdue Pharma's $7.4 billion deal to settle thousands of lawsuits over the toll of the opioid epidemic and pay victims, prosecutors in the case told USA ...